These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1087 related articles for article (PubMed ID: 32498469)

  • 1. Discovery of New Schiff Bases Tethered Pyrazole Moiety: Design, Synthesis, Biological Evaluation, and Molecular Docking Study as Dual Targeting DHFR/DNA Gyrase Inhibitors with Immunomodulatory Activity.
    Hassan AS; Askar AA; Naglah AM; Almehizia AA; Ragab A
    Molecules; 2020 Jun; 25(11):. PubMed ID: 32498469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibacterial Evaluation, In Silico Characters and Molecular Docking of Schiff Bases Derived from 5-aminopyrazoles.
    Hassan AS; Askar AA; Nossier ES; Naglah AM; Moustafa GO; Al-Omar MA
    Molecules; 2019 Aug; 24(17):. PubMed ID: 31466322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of novel multi-substituted benzo-indole pyrazole schiff base derivatives with antibacterial activity targeting DNA gyrase.
    Liu H; Chu ZW; Xia DG; Cao HQ; Lv XH
    Bioorg Chem; 2020 Jun; 99():103807. PubMed ID: 32272364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, and antibacterial activity of novel 4,5-dihydro-1H-pyrazole derivatives as DNA gyrase inhibitors.
    Liu JJ; Sun J; Fang YB; Yang YA; Jiao RH; Zhu HL
    Org Biomol Chem; 2014 Feb; 12(6):998-1008. PubMed ID: 24382549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel 1,2,4-oxadiazole-chalcone/oxime hybrids as potential antibacterial DNA gyrase inhibitors: Design, synthesis, ADMET prediction and molecular docking study.
    Ibrahim TS; Almalki AJ; Moustafa AH; Allam RM; Abuo-Rahma GEA; El Subbagh HI; Mohamed MFA
    Bioorg Chem; 2021 Jun; 111():104885. PubMed ID: 33838559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, in vitro antimicrobial evaluation and molecular docking studies of indol-2-one tagged with morpholinosulfonyl moiety as DNA gyrase inhibitors.
    Salem MA; Ragab A; El-Khalafawy A; Makhlouf AH; Askar AA; Ammar YA
    Bioorg Chem; 2020 Mar; 96():103619. PubMed ID: 32036161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel heterocyclic hybrids of pyrazole targeting dihydrofolate reductase: design, biological evaluation and
    Othman IMM; Gad-Elkareem MAM; Amr AEE; Al-Omar MA; Nossier ES; Elsayed EA
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1491-1502. PubMed ID: 32668994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydrazonoyl bromide precursors as DHFR inhibitors for the synthesis of bis-thiazolyl pyrazole derivatives; antimicrobial activities, antibiofilm, and drug combination studies against MRSA.
    Ibrahim SA; Fayed EA; Rizk HF; Desouky SE; Ragab A
    Bioorg Chem; 2021 Nov; 116():105339. PubMed ID: 34530234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial screening and pharmacokinetic profiling of novel phenyl-[1,2,4]triazolo[4,3-a]quinoxaline analogues targeting DHFR and E. coli DNA gyrase B.
    Omar AM; Alswah M; Ahmed HEA; Bayoumi AH; El-Gamal KM; El-Morsy A; Ghiaty A; Afifi TH; Sherbiny FF; Mohammed AS; Mansour BA
    Bioorg Chem; 2020 Mar; 96():103656. PubMed ID: 32062449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibacterial Evaluation and Virtual Screening of New Thiazolyl-Triazole Schiff Bases as Potential DNA-Gyrase Inhibitors.
    Nastasă C; Vodnar DC; Ionuţ I; Stana A; Benedec D; Tamaian R; Oniga O; Tiperciuc B
    Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29324679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of Novel Triazole-Containing Pyrazole Ester Derivatives as Potential Antibacterial Agents.
    Chu MJ; Wang W; Ren ZL; Liu H; Cheng X; Mo K; Wang L; Tang F; Lv XH
    Molecules; 2019 Apr; 24(7):. PubMed ID: 30987179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted potent antimicrobial benzochromene-based analogues: Synthesis, computational studies, and inhibitory effect against 14α-Demethylase and DNA Gyrase.
    Fouda AM; Hassan AH; Eliwa EM; Ahmed HEA; Al-Dies AM; Omar AM; Nassar HS; Halawa AH; Aljuhani N; El-Agrody AM
    Bioorg Chem; 2020 Dec; 105():104387. PubMed ID: 33130344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. One-pot synthesis and molecular docking of some new spiropyranindol-2-one derivatives as immunomodulatory agents and in vitro antimicrobial potential with DNA gyrase inhibitor.
    Salem MA; Ragab A; Askar AA; El-Khalafawy A; Makhlouf AH
    Eur J Med Chem; 2020 Feb; 188():111977. PubMed ID: 31927313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular docking, discovery, synthesis, and pharmacological properties of new 6-substituted-2-(3-phenoxyphenyl)-4-phenyl quinoline derivatives; an approach to developing potent DNA gyrase inhibitors/antibacterial agents.
    Alagumuthu M; Arumugam S
    Bioorg Med Chem; 2017 Feb; 25(4):1448-1455. PubMed ID: 28094220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, green one-pot synthesis and molecular docking study of novel N,N-bis(cyanoacetyl)hydrazines and bis-coumarins as effective inhibitors of DNA gyrase and topoisomerase IV.
    Metwally NH; Abdallah SO; Mohsen MMA
    Bioorg Chem; 2020 Apr; 97():103672. PubMed ID: 32145481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclohexyl amide-based novel bacterial topoisomerase inhibitors with prospective GyrA-binding fragments.
    Kolarič A; Novak D; Weiss M; Hrast M; Zdovc I; Anderluh M; Minovski N
    Future Med Chem; 2019 May; 11(9):935-945. PubMed ID: 31140866
    [No Abstract]   [Full Text] [Related]  

  • 17. Synthesis, antimicrobial evaluation, DNA gyrase inhibition, and in silico pharmacokinetic studies of novel quinoline derivatives.
    El-Shershaby MH; El-Gamal KM; Bayoumi AH; El-Adl K; Ahmed HEA; Abulkhair HS
    Arch Pharm (Weinheim); 2021 Feb; 354(2):e2000277. PubMed ID: 33078877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, Docking Studies, and In Vitro Evaluation of Some Novel Thienopyridines and Fused Thienopyridine-Quinolines as Antibacterial Agents and DNA Gyrase Inhibitors.
    Mohi El-Deen EM; Abd El-Meguid EA; Hasabelnaby S; Karam EA; Nossier ES
    Molecules; 2019 Oct; 24(20):. PubMed ID: 31658631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of novel indolin-2-one derivative incorporating thiazole moiety as DHFR and quorum sensing inhibitors: Synthesis, antimicrobial, and antibiofilm activities with molecular modelling study.
    Alzahrani AY; Ammar YA; Abu-Elghait M; Salem MA; Assiri MA; Ali TE; Ragab A
    Bioorg Chem; 2022 Feb; 119():105571. PubMed ID: 34959177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction and Docking Studies of Novel Pyrimido[4,5-b]quinolines as Antimicrobial Agents.
    Bakr RB; El Azab IH; Elkanzi NAA
    Chem Biodivers; 2024 Jun; 21(6):e202400200. PubMed ID: 38570192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 55.